The adult congenital heart disease (CHD) population has surpassed the paediatric CHD population. Half of all mortality caused by CHD occurs in adulthood; in some patients, it occurs during surgery. We sought to assess the potential risk factors for adverse outcome after cardiac operations in adults with CHD, and to evaluate the predictive power of the Aristotle score models for hospital mortality.
INTRODUCTION
Due to tremendous advances in the medical and surgical care of children with congenital heart defects (CHDs), the prevalence of CHD among adults is increasing [1] . In 2000, there were nearly equal numbers of adults and children with severe CHD [2] . By 2005, the total adult CHD population had reached 1 million in the USA [3] and had surpassed the paediatric CHD population [4] . CHD-related mortality is declining in both children and adults [5] . However, mortality among adults is still significant. More than half of all mortality caused by CHD occurs in adulthood [5] . Hospital mortality upon surgery for CHD in adults also contributes to CHD-related mortality in adulthood.
Adults with CHD are referred to surgery for four reasons: (i) primary correction of previously untreated defects, (ii) surgical treatment of residual defects after prior correction, (iii) surgical treatment of new pathologies associated with CHD and prior operations and (iv) treatment of acquired cardiac comorbidity such as coronary artery disease. Hospital mortality related to these operations is 3-4% [6] . Therefore, risk assessment tools are required for the planning of treatment strategies.
The EuroSCORE is well established for adults presenting with acquired heart disease [7, 8] . However, it is not suitable for patients with CHD [6] . The Aristotle and Risk Adjustment in Congenital Heart Surgery-1 score models correlate well with hospital mortality of children with CHD [9] . We sought to assess potential risk factors for adverse outcome after cardiac operations in adults with CHD, and to evaluate the predictive power of the Aristotle score models for hospital mortality.
PATIENTS AND METHODS
The study population comprised all consecutive adult patients who underwent surgery for congenital heart disease at our department between January 2005 and December 2008. According to Dore and Somerville and colleagues, patients aged 16 or more at the time of surgery were included [10] . Institutional Review Board approval was obtained to conduct this retrospective follow-up study.
The procedure dependent and independent factors, as well as the outcome factors were evaluated according to the nomenclature of the European Association for Cardio-Thoracic Surgery (EACTS) Congenital Database (http://www.eactscongenitaldb.org) [11] . Basic data were verified by an external audit. The corresponding Aristotle basic complexity (ABC) and Aristotle comprehensive complexity (ACC) scores were assigned to each operation. For operations including more than one procedure, the procedure with the highest ABC score was defined as the primary procedure. ABC and ACC scores were supplied by the Aristotle Institute, Denver, CO, USA (http://www.aristotleinstitute. org) [12] .
Frequencies are given as absolute numbers and percentages. Continuous data are expressed in terms of the mean and standard deviation. Fisher's exact test was performed to detect significant differences between groups. For comparison of continuous variables between two groups, the unpaired t-test was used (two-tailed tests were used for all analyses). Items with numbers <5 were excluded from analyses. The discriminatory power of the scores was assessed using the area under the receiver operating characteristics (AuROC) curve. Analyses were performed with SPSS 18.0 for Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
During 542 operations, 773 procedures were performed. They are listed in Table 1 . Procedure-dependent and independent factors are listed in Table 2 . A total of 271 operations (50.0%) were performed on males. The mean age at the time of the operation was 30.7 ± 12.8 years. The mean body mass index was 28.5 ± 113.7.
Thirteen deaths occurred during hospital admittance or within the first 30 postoperative days (2.4%). Clinical data and causes of death are listed in Table 3 . A total of 569 complications occurred after 291 operations (53.7%, 291 operations with complications of 542 operations; Table 4 ).
Tricuspid valve replacement (P = 0.009), and mitral valve replacement (P < 0.001) emerged as procedure-dependent risk factors for 30-day mortality (Table 1) . Elevated lung resistances and biventricular repair (P = 0.002), hypothyroidism (P = 0.002), redosternotomy after one to three previous operations (P = 0.003) and redosternotomy after more than three previous operations (P = 0.010) emerged as procedure-independent risk factors for 30-day mortality (Table 2 ). There was no significant influence of sex, age or body mass index on 30-day mortality.
Tricuspid valve replacement (P < 0.001), tricuspid valvuloplasty (P = 0.006), mitral valve replacement (P = 0.003), implantation of a systemic to pulmonary artery shunt (P = 0.009) and surgical ablation of arrhythmia (P = 0.024) emerged as proceduredependent risk factors for complications. Closure of an atrial septal defect emerged as a protective factor for complications (P < 0.001; Table 1 ). Myocardial dysfunction (P = 0.014), elevated lung resistances and biventricular repair (P = 0.004), hypothyroidism (P = 0.002) and redosternotomy after one to three previous operations (P < 0.001) emerged as procedure-independent risk factors for complications. Minimal invasive anterolateral thoracotomy emerged as a protective factor for complications (P < 0.001; Table 2 ). There was no significant influence of sex, age or body mass index on complications.
Mean ABC and ACC scores were 6.6 ± 2.3, and 9.0 ± 3.7, respectively. The AuROC of the ABC score for 30-day mortality was 0.663 [95% confidence interval (CI) 0.570-0.756, P = 0.044]. The AuROC of the ACC score for 30-day mortality was 0.755 (95% CI 0.668-0.841, P = 0.002; Fig. 1 ). The AuROC of the ABC score for complications was 0.634 (95% CI 0.587-0.682, P < 0.001). The AuROC of the ACC score for complications was 0.670 (95% CI 0.624-0.715, P < 0.001; Fig. 2 ).
DISCUSSION
In the present study, we assessed potential risk factors for an adverse outcome after cardiac operations in adults with CHD, and we evaluated the predictive power of the Aristotle score models for hospital survival of adults after surgery for CHD. The ABC score does not discriminate well between patients with high or low risk for hospital mortality. The ACC score discriminates well between patients with high or low risk for hospital mortality.
Why is the ABC score not appropriate? Adults with CHD are often reoperated on because of subsequent pathologies, developing as the consequence of CHD. These reoperations may require combinations of procedures. Aortic root replacement and concomitant conduit reoperation following a Fallot repair or aortic root replacement and concomitant pulmonary artery patch plasty following an arterial switch operation, for example. The ABC score is not appropriate since it is determined by the primary procedure only [13] , and does not include combinations of procedures.
The predictive power of the ACC score is more accurate compared with the ABC score because additional proceduredependent factors are considered [14] . Therefore, a higher score can be assigned to complex and time-consuming operations. Concomitant repair of suboartic stenosis during valvuloplasty of the left atrioventricular valve, for example, is such a proceduredependent factor. The ACC score also considers further procedure-dependent factors that increase the complexity of a procedure, for example an annular abscess due to infective endocarditis, which complicates mitral valve replacement. The ACC score also considers procedure-independent factors. Many of them, such as impaired renal function [15, 16] , and chromosomal abnormalities [17, 18] , are associated with adverse outcome. Furthermore, the ACC score emphasizes the influence of repeated reoperations [19, 20] , which were required in >53% of the present patient population.
In the present study, we included all items of the ACC score into univariate analyses for association with early mortality. Accordingly, mitral and tricuspid valve replacement emerged as procedure-dependent risk factors for early mortality in the present study population. However, the score value of these procedures (7.5) is less than one point above the mean ABC score in the present study. Two of the non-survivors had undergone tricuspid valve replacement in the setting of a systemic right ventricle. Three of the non-survivors had undergone tricuspid or mitral valve replacement in the setting of a functionally single ventricle. This indicates, that especially in grown ups with congenital heart disease (GUCH), it might be more important under which haemodynamic setting procedures are performed, than which procedure is performed. For GUCH, including the factors 'right systemic ventricle' and 'functionally single ventricle' might improve the predictive value of the Aristotle score models for early mortality. A significant association between pulmonary hypertension and all-cause mortality in GUCH has already been shown by Lowe et al. [21] . To the best of our knowledge, the present report is the first to demonstrate a significant association of increased pulmonary vascular resistance and early mortality upon cardiac operations. The same is true for the observed significant association of hypothyreosis and early mortality. An increased number of redo operations emerged as a significant surgical technical risk factor for early mortality. This is in line with the findings of Giamberti et al. [20] , who observed the previous number of operations to be associated with severe morbidity, but not with mortality.
The predictive power of the ACC score may be improved. Many items included in the ACC score did not reach statistical significance for an association with early mortality in the present study. This may be attributed to a small number of patients presenting with those potential risk factors, and to the small number of events in the present study population. Some potential risk factors are not included in the ACC score. Looking at the non-survivors of the present study, i.e. 'functionally single ventricle' may emerge as an important risk factor for early mortality. Van Gameren et al. [22] could show that the predictive power of the ACC score can be improved by including just age at the time of surgery. Vogt et al. [23] demonstrated a significant association of cyanosis, and impaired NYHA functional class on death or prolonged intensive care unit stay. These are all potential risk factors, which are currently not included in the ACC score. Further investigations may help to discuss the ACC score as it currently exists, and help to evaluate new potential risk factors.
Is it justified to estimate hospital mortality in adults with CHD with the Aristotle score models? In our opinion, the ACC score is currently the best model to estimate the complexity of an operation performed for CHD. The nomenclature of the scores [24] is universally accepted and an integral component of the EACTS Congenital Database [11] . This database also includes procedures performed on adults. The online reports of the database allow stratification by the ages below or above 18 years. Therefore, we think it is legitimate to evaluate the Aristotle score models on adults.
How time-consuming is it to apply the ACC score? The ACC score includes many procedure-dependent and patientdependent factors. However, the surgeon must know all of them to meticulously plan an operation. Therefore, prospective scoring for the present study at the day of the operation did not take more than a few minutes, because all the information is on hand. It can easily be done with the use of the Aristotle Institute online tool [12] . It has since become routine practice at our centre to report on each patient's score prior to our interdisciplinary conferences.
Study limitations
The score models are evaluated at a single centre over a 4-year time period. Types of procedures, patients and individual results may be centre-specific and specific for a certain time period. Therefore, influencing factors in the present study population may not have a negative impact on outcome at other centres or in the future. The goal of the Aristotle score models was performance evaluation, not outcome prediction [25] . However, at the present time, there is no scoring system available for outcome prediction unless surgical mortality is significant. Therefore, we think it is justified to assess the Aristotle score models. The present manuscript presents a large number of patients for a single centre. However, since the number of events is relatively low, only limited conclusions can be drawn. Ideally, validation of the applicability of the Aristotle score models for the GUCH population has to be confirmed by multicentre studies involving much higher numbers of patients. Since these studies are not available at the present, our findings may encourage larger studies or eventually, meta-analyses. In this regard, I have three questions for you. My first question comes from another publication from Rotterdam, from Dr. Van Gameren, who mentioned that it was interesting to add points per decade of age. In your conclusion and in the manuscript, you conclude that age was not a significant factor for mortality. Can you comment on this?
Dr Schreiber: You are quite right. Of the 13 patients who died, the majority were patients with single ventricle physiology; most had a dominant right ventricle and were in New York Heart Association group III or worse. But you are right, to the best of my knowledge, age wasn't a risk factor. However, I think if we would have added single ventricle and NYHA, the risk adequacy would have been better. We should try with you and other members of the EACTS to further improve scores in the near future, but I would be happy to have your suggestions as well on how to move forward.
Dr Lacour-Gayet: Well, I think that when we're dealing with a patient who is 40 years of age and we add to a congenital disease the acquired diseases of the general population, including coronary artery disease and lung disease, that is changing the pathology.
I have noticed also in your manuscript that mitral valve replacement or repair and tricuspid valve replacement or repair were significantly associated with a higher mortality. Isn't it that this AV valve dysfunction is more a consequence of a myocardial dysfunction in the long-term complex congenital heart disease than an anatomical problem with the AV valves?
Dr Schreiber: That could well be, but we have used the score as it is and filled in as much information as we had. Again, your question is pointing out that we might need to do a few modifications to delineate how sick the patient really is at the time of surgery, because very often it seems that not just surgery implies a risk but rather the underlying morphology.
Dr Lacour-Gayet: The last question, we have in mind to really increase the power of redo sternotomy. Doing a fourth or a fifth sternotomy in a patient who had a previous Fontan failure is really very challenging. Would you agree to giving more points, more power to redo sternotomy when they go over 3?
Dr Schreiber: I'm not sure. I think we need to discuss that. There have to be quite a few members answering that point. Sometimes, as you know, opening a patient for the third time might be easier than opening someone for the second time. You cannot truly predict how difficult resternotomy is. I find that may be a bit of a crude measure. I can't completely agree with you. It depends on when the patient was operated the first time, maybe at which institution, what technique was used. I think to make a cut-off that after a fourth reoperation, it gets really, really difficult. I'm not sure. Maybe we need to hear other surgeons in the room. Well, what do you personally think? Do you think there could be a cut-off of a third operation, fourth, fifth?
Dr Lacour-Gayet: Well, my personal opinion is not very important. I personally suffer when I reopen the sternum for the fifth time, but if you feel fine with that … Dr J. Jacobs (St. Petersburg, FL, USA): I know that Joe Dearani from the Mayo Clinic has published data where he has a graph, and on the X-axis is the number of redo sternotomies and on the Y-axis is mortality, and it goes
